Objectives-The differential expression of several accessory/activation molecules (CD26, CD29, CD45RA, CD25, MLR4, HLA-DR) on peripheral blood CD4+ and CD8+ T lymphocytes in patients with scleroderma was compared with that in controls and patients with other connective systemic diseases to look for evidence of the involvement of T cells in the disease process of scleroderma. Methods-The two colour expression of surface molecules by circulating T cells was analysed with a panel of monoclonal antibodies and flow cytometry in 17 patients with scleroderma, 10 patients with systemic lupus erythematosus, and five patients with rheumatoid arthritis, and the results compared with those for 10 normal controls. The two colour T CD4+ phenotype was further compared between patients with active and quiescent disease in these patients with scleroderma. The coexpression of surface molecules by CD4+ T cells was also analysed by three colour flow cytometry in eight patients with scleroderma. Results-Patients with scleroderma showed increased CD4+CD26+ and CD4+CD25+ percentages and absolute numbers and decreased CD8+CD29+ percentages compared with controls. Moreover, a significant correlation between the higher CD4+CD26+ T cell percentage and absolute cell numbers with disease activity was observed. Most of the CD4+ peripheral blood T cells from patients with scleroderma showed the CD26+CD45RA-phenotype by three colour flow cytometry analysis. Conclusions-The distinctive pattern of early helper memory T cell activation in these patients with rapidly evolving scleroderma supports the role of a T cell mediated mechanism in the progression of scleroderma.
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Objectives-The differential expression of several accessory/activation molecules (CD26, CD29, CD45RA, CD25, MLR4, HLA-DR) on peripheral blood CD4+ and CD8+ T lymphocytes in patients with scleroderma was compared with that in controls and patients with other connective systemic diseases to look for evidence of the involvement of T cells in the disease process of scleroderma. Methods-The two colour expression of surface molecules by circulating T cells was analysed with a panel of monoclonal antibodies and flow cytometry in 17 patients with scleroderma, 10 patients with systemic lupus erythematosus, and five patients with rheumatoid arthritis, and the results compared with those for 10 normal controls. The two colour T CD4+ phenotype was further compared between patients with active and quiescent disease in these patients with scleroderma. The coexpression of surface molecules by CD4+ T cells was also analysed by three colour flow cytometry in eight patients with scleroderma. Results-Patients with scleroderma showed increased CD4+CD26+ and CD4+CD25+ percentages and absolute numbers and decreased CD8+CD29+ percentages compared with controls. Moreover, a significant correlation between the higher CD4+CD26+ T cell percentage and absolute cell numbers with disease activity was observed. Most of the CD4+ peripheral blood T cells from patients with scleroderma showed the CD26+CD45RA-phenotype by three colour flow cytometry analysis. Conclusions-The distinctive pattern of early helper memory T cell activation in these patients with rapidly evolving scleroderma supports the role of a T cell mediated mechanism in the progression of scleroderma. The surface expression of lymphocyte adhesion proteins, also known as accessory molecules, may account for the different activation requirements and effector functions of CD4+ T cell subclasses. Reciprocal subpopulations of peripheral blood T cells, naive and memory, are defined by coordinate expression of multiple adhesion/activation molecules6 7 and different isoforms of CD45 Ag.8 Naive and memory cells, at least in CD4+ T cells, correspond to the 'helper inducer' and 'suppressor inducer' T cell subsets8 previously identified by monoclonal antibodies (MoAbs) 4B4 (directed against CD29)9 and 2H4 (directed against CD45R).'0 The two CD4+ subsets show a distinct recirculatory pathway, with preferential migration of helper memory cells into the site of inflammation." Transition from the naive to the memory phenotype after antigen stimulation is accompanied by alterations in the surface density of adhesion molecules. The increased expression of lymphocyte receptors for major extracellular matrix proteins, such as the integrin very late antigens (VLA) and CD26, plays an important part in local cell positioning and differentiation. 12 Although the role of T cell hyperactivity is widely accepted in scleroderma, few data have been reported on peripheral blood T cell abnormalities in different stages of the disease or on the distinctive pattern of T cell activation with respect to other systemic connective tissue diseases.
In this study we examined the differential expression of several accessory/activation molecules (CD29, CD45RA, CD26, CD25, HLA-DR, and MLR4) on peripheral blood T cell fractions in patients with scleroderma and compared them with controls using two colour flow cytometry. We also investigated the distribution of these surface molecules on peripheral blood T cell subsets in two other groups of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA 
ANTIBODIES
The following MoAbs were used: antimonomorphic HLA-DR Ag (OKDR), anti-MLR4 T cell Ag (Tec-MLR4), anti-CD4 (OKT4; anti-Leu3), anti-CD8 (OKT8; antiLeu2), anti-CD26 (Tal, now identified with the ectoenzyme dipeptidylpeptidase IV),'9 anti-CD25 (Tec-IL-2-R), anti-CD29 (4B4, integrin f31 subunit of the VIA heterodimeric protein), and anti-CD45RA (2H4, the high molecular weight isoform of the leucocyte common antigen family). Monoclonal and CD4+CD25+ absolute cell numbers (p<0.02), compared with the quiescent group. Compared with controls, the patients with active scleroderma showed higher CD4+ (p<005) cell percentages and higher CD4+CD26+ and CD4+CD25+ T cell percentages (p<0001, p=0 001 respectively) and T cell absolute numbers (p=0 001, p<0001 respectively). CD4+CD26+/CD4+ and CD4+CD25+/CD4+ ratios were also increased in patients with active scleroderma compared with controls (p<0 01, p<0 01 Table 2 Two colourflow cytometry analysis (FacScan) of CD4+peripheral blood lymphocytes in patients with scleroderma, systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and in healthy controls. Results are mean (SD) percentages ofpositivefluorescent lymphocytes
Scleroderma (n=17) 48-9 (7 8) 39-9 (6 8)t Table 4 Two colourflow cytometry analysis (FacScan) of CD4+ peripheral blood lymphocytes from patients with active and quiescent disease and healthy controls. Percentages and ratios ofpositive subsets are reported in part (a) and absolute numbers in part (b). Results CD45RA negative (fig iB) . The MLR4+ cells were mostly included in the fluorescence area of CD45RA Ag (data not shown). The CD4+CD26+ cells again showed low levels of CD25 expression, and only a few cells coexpressed DR Ag (fig 2) . 
